Unilife Newsroom Blog

Alan Shortall of Unilife (NASDAQ: UNIS) Hits the Road in September

Unilife's Chief Executive Officer Alan Shortall will be presenting at three upcoming investor conferences taking in New York and Boston during the month of September, 2010.

1. Monday, September 13, Shortall will present at the Rodman and Renshaw Annual Global Investment Conference in New York at 10:25 a.m. EDT.
2. On Wednesday, September 15, Shortall will present at the Stifel Nicolaus Healthcare Conference in Boston at 8:35 a.m. EDT.
3. On Monday, September 20, Mr. Shortall will present at the UBS Global Life Sciences Conference in New York at 4:00 p.m. EDT.

Each of the conference presentations will be broadcast over the Internet as a "live" listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm. An archive of each event will also be available for those unable to listen live.

About Unilife Corporation

Unilife Corporation is a U.S.-based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Primary target customers for Unilife products include pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities and patients who self-administer prescription medication. These patent-protected syringes incorporate automatic and fully-integrated safety features which are designed to protect those at risk of needlestick injuries and unsafe injection practices. Unilife is ISO 13485 certified and has FDA-registered medical device manufacturing facilities in Pennsylvania.